Baicalin Ameliorates Dexamethasone-Induced Osteoporosis by Regulation of the RANK/RANKL/OPG Signaling Pathway

References

• CorneliusC, KoverechG, CrupiR, et al. Osteoporosis and alzheimer pathology: role of cellular stress response and hormetic redox signaling in aging and bone remodeling. Front Pharmacol. 2014;5:120. doi:10.3389/fphar.2014.0012024959146
   PubMed Web of Science ®Google Scholar
• GenantHK, CooperC, PoorG, et al. Interim report and recommendations of the World Health Organization task-force for osteoporosis. Osteoporos Int. 1999;10:259–264. doi:10.1007/s00198005022410692972
   PubMed Web of Science ®Google Scholar
• SatoAY, CregorM, Delgado-CalleJ, et al. Protection from glucocorticoid-induced osteoporosis by anti-catabolic signaling in the absence of sost/sclerostin. J Bone Miner Res. 2016;31:1791–1802. doi:10.1002/jbmr.286927163932
   PubMed Web of Science ®Google Scholar
• TheoleyreS, WittrantY, TatSK, et al. The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling. Cytokine Growth Factor Rev. 2004;15:457–475. doi:10.1016/j.cytogfr.2004.06.00415561602
   PubMed Web of Science ®Google Scholar
• JiangL, SongJ, HuX, et al. The proteasome inhibitor bortezomib inhibits inflammatory response of periodontal ligament cells and ameliorates experimental periodontitis in rats. J Periodontol. 2017;88:473–483. doi:10.1902/jop.2016.16039627982724
   PubMed Web of Science ®Google Scholar
• KurinamiH, ShimamuraM, NakagamiH, et al. A novel therapeutic peptide as a partial agonist of RANKL in ischemic stroke. Sci Rep. 2016;6:38062. doi:10.1038/srep3806227897273
   PubMed Web of Science ®Google Scholar
• MariaS, SamsonrajRM, MunmunF, et al. Biological effects of melatonin on osteoblast/osteoclast cocultures, bone, and quality of life: implications of a role for MT2 melatonin receptors, MEK1/2, and MEK5 in melatonin-mediated osteoblastogenesis. J Pineal Res. 2018;64:e12465. doi:10.1111/jpi.12465
   Web of Science ®Google Scholar
• HollowayWR, CollierFM, AitkenCJ, et al. Leptin inhibits osteoclast generation. J Bone Miner Res. 2002;17:200–209. doi:10.1359/jbmr.2002.17.2.20011811550
   PubMed Web of Science ®Google Scholar
• YuanY, ZhangL, TongX, et al. Mechanical stress regulates bone metabolism through MicroRNAs. J Cell Physiol. 2017;232:1239–1245. doi:10.1002/jcp.2568827861865
   PubMed Web of Science ®Google Scholar
• MontalciniT, RomeoS, FerroY, et al. Osteoporosis in chronic inflammatory disease: the role of malnutrition. Endocrine. 2013;43:59–64. doi:10.1007/s12020-012-9813-x23055015
   PubMed Web of Science ®Google Scholar
• LewieckiEM. Safety and tolerability of denosumab for the treatment of postmenopausal osteoporosis. Drug Healthc Patient Saf. 2011;3:79–91. doi:10.2147/dhps.s772722279412
   PubMedGoogle Scholar
• LianC, WuZ, GaoB, et al. Melatonin reversed tumor necrosis factor-alpha-inhibited osteogenesis of human mesenchymal stem cells by stabilizing SMAD1 protein. J Pineal Res. 2016;61:317–327. doi:10.1111/jpi.1234927265199
   PubMed Web of Science ®Google Scholar
• SharanK, LewisK, FurukawaT, YadavVK. Regulation of bone mass through pineal-derived melatonin-MT2 receptor pathway. J Pineal Res. 2017;63:e12423. doi:10.1111/jpi.12423
   PubMed Web of Science ®Google Scholar
• LiT, JiangS, LuC, et al. Melatonin: another avenue for treating osteoporosis? J Pineal Res. 2019;66:e12548. doi:10.1111/jpi.1254830597617
   PubMed Web of Science ®Google Scholar
• TellaSH, GallagherJC. Prevention and treatment of postmenopausal osteoporosis. J Steroid Biochem Mol Biol. 2014;142:155–170. doi:10.1016/j.jsbmb.2013.09.00824176761
   PubMed Web of Science ®Google Scholar
• MitaniM, MiuraY, SauraR, et al. Estrogen specifically stimulates expression and production of osteoprotegerin from rheumatoid synovial fibroblasts. Int J Mol Med. 2005;15:827–832.15806305
   PubMed Web of Science ®Google Scholar
• YeonJT, KimK-J, ChoiS-W, et al. Anti-osteoclastogenic activity of praeruptorin A via inhibition of p38/Akt-c-Fos-NFATc1 signaling and PLCgamma-independent Ca2+ oscillation. PLoS One. 2014;9:e88974. doi:10.1371/journal.pone.008897424586466
   PubMed Web of Science ®Google Scholar
• HeL, LeeJ, JangJH, et al. Ginsenoside Rh2 inhibits osteoclastogenesis through down-regulation of NF-kappaB, NFATc1 and c-Fos. Bone. 2012;50:1207–1213. doi:10.1016/j.bone.2012.03.02222484180
   PubMed Web of Science ®Google Scholar
• ParkSH, KimJ-Y, CheonY-H, et al. Protocatechuic acid attenuates osteoclastogenesis by downregulating JNK/c-Fos/NFATc1 signaling and prevents inflammatory bone loss in mice. Phytother Res. 2016;30:604–612. doi:10.1002/ptr.556526792397
   PubMed Web of Science ®Google Scholar
• QuB, XiaX, YanM, et al. miR-218 is involved in the negative regulation of osteoclastogenesis and bone resorption by partial suppression of p38MAPK-c-Fos-NFATc1 signaling: potential role for osteopenic diseases. Exp Cell Res. 2015;338:89–96. doi:10.1016/j.yexcr.2015.07.02326216483
   PubMed Web of Science ®Google Scholar
• LiH, WangM, LiangQ, et al. Urinary metabolomics revealed arsenic exposure related to metabolic alterations in general Chinese pregnant women. J Chromatogr A. 2017;1479:145–152. doi:10.1016/j.chroma.2016.12.00727988079
   PubMed Web of Science ®Google Scholar
• MingJ, ZhuonengL, GuangxunZ. Protective role of flavonoid baicalin from scutellaria baicalensis in periodontal disease pathogenesis: a literature review. Complement Ther Med. 2018;38:11–18. doi:10.1016/j.ctim.2018.03.01029857875
   PubMed Web of Science ®Google Scholar
• CaiLL, LiuGY, TzengCM. Genome-wide DNA methylation profiling and its involved molecular pathways from one individual with thyroid malignant/benign tumor and hyperplasia: a case report. Medicine. 2016;95:e4695. doi:10.1097/md.000000000000469527583899
   PubMed Web of Science ®Google Scholar
• LuanY, ChaoS, JuZ-Y, et al. Therapeutic effects of baicalin on monocrotaline-induced pulmonary arterial hypertension by inhibiting inflammatory response. Int Immunopharmacol. 2015;26:188–193. doi:10.1016/j.intimp.2015.01.00925601497
   PubMed Web of Science ®Google Scholar
• JinJ, ChenY, WangD, et al. The inhibitory effect of sodium baicalin on oseltamivir-resistant influenza A virus via reduction of neuraminidase activity. Arch Pharm Res. 2018;41:664–676. doi:10.1007/s12272-018-1022-629572682
   PubMed Web of Science ®Google Scholar
• WangQ, XuH, ZhaoX. Baicalin inhibits human cervical cancer cells by suppressing protein kinase C/Signal Transducer and Activator of Transcription (PKC/STAT3) signaling pathway. Med Sci Monit. 2018;24:1955–1961. doi:10.12659/MSM.90964029610452
   PubMed Web of Science ®Google Scholar
• DongSJ, ZhongY-Q, LuW-T, et al. Baicalin inhibits lipopolysaccharide-induced inflammation through signaling NF-kappaB pathway in HBE16 airway epithelial cells. Inflammation. 2015;38:1493–1501. doi:10.1007/s10753-015-0124-225630720
   PubMed Web of Science ®Google Scholar
• LiuJ, WeiY, LuoQ, et al. Baicalin attenuates inflammation in mice with OVA-induced asthma by inhibiting NF-kappaB and suppressing CCR7/CCL19/CCL21. Int J Mol Med. 2016;38:1541–1548. doi:10.3892/ijmm.2016.274327666000
   PubMed Web of Science ®Google Scholar
• PeiZ, WangB, ZhangF, et al. Response of human periodontal ligament cells to baicalin. J Periodontol. 2014;85:1283–1290. doi:10.1902/jop.2014.13063524476549
   PubMed Web of Science ®Google Scholar
• WangGF, WuZF, WanL, WangQT, ChenFM. Influence of baicalin on the expression of receptor activator of nuclear factor-kappaB ligand in cultured human periodontal ligament cells. Pharmacology. 2006;77:71–77. doi:10.1159/00009285316636611
   PubMed Web of Science ®Google Scholar
• GuoAJ, ChoiRCY, CheungAWH, et al. Baicalin, a flavone, induces the differentiation of cultured osteoblasts: an action via the Wnt/beta-catenin signaling pathway. J Biol Chem. 2011;286:27882–27893. doi:10.1074/jbc.M111.23628121652696
   PubMed Web of Science ®Google Scholar
• SpragueJ, BayraktarogluL, BradfordY, et al. The zebrafish information network: the zebrafish model organism database provides expanded support for genotypes and phenotypes. Nucleic Acids Res. 2007;36:D768–D772. doi:10.1093/nar/gkm95617991680
   PubMed Web of Science ®Google Scholar
• ChenJR, LaiYH, TsaiJJ, HsiaoCD. Live fluorescent staining platform for drug-screening and mechanism-analysis in zebrafish for bone mineralization. Molecules. 2017;22. doi:10.3390/molecules22122068
   Web of Science ®Google Scholar
• LuoS, YangY, ChenJ, et al. Tanshinol stimulates bone formation and attenuates dexamethasone-induced inhibition of osteogenesis in larval zebrafish. J Orthop Translat. 2016;4:35–45. doi:10.1016/j.jot.2015.07.00230035064
   PubMed Web of Science ®Google Scholar
• HanleyDA, IoannidisG, AdachiJD. Etridronate therapy in the treatment and prevention of osteoporosis. J Clin Densitom. 2000;3:79–95. doi:10.1385/JCD:3:1:07910745305
   PubMed Web of Science ®Google Scholar
• MartinRB, IshidaJ. The relative effects of collagen fiber orientation, porosity, density, and mineralization on bone strength. J Biomech. 1989;22:419–426. doi:10.1016/0021-9290(89)90202-92777816
   PubMed Web of Science ®Google Scholar
• AnbinderAL, MoraesRM, LimaGMG, et al. Periodontal disease exacerbates systemic ovariectomy-induced bone loss in mice. Bone. 2016;83:241–247. doi:10.1016/j.bone.2015.11.01426620086
   PubMed Web of Science ®Google Scholar
• FeizeW, MengL, YanniL, et al. A randomized controlled study to observe the efficacy of external treatment with a traditional chinese medicine herbal ointment on malignant plural effusion: outcome report and design review. Integr Cancer Ther. 2017;16:473–478. doi:10.1177/153473541666019327431570
   PubMed Web of Science ®Google Scholar
• WangS, ZangW, YangY, et al. Tanshinone IIA and baicalin inhibiting the formation of benzo[a]pyrene and benzo[a]pyrene induced cytotoxicity: correlation with scavenging free radical. Environ Toxicol Pharmacol. 2013;36:403–410. doi:10.1016/j.etap.2013.05.00323764461
   PubMed Web of Science ®Google Scholar
• DindaB, DindaS, DasSharmaS, et al. Therapeutic potentials of baicalin and its aglycone, baicalein against inflammatory disorders. Eur J Med Chem. 2017;131:68–80. doi:10.1016/j.ejmech.2017.03.00428288320
   PubMed Web of Science ®Google Scholar
• WangG, LiangJ, GaoL-R, et al. Baicalin administration attenuates hyperglycemia-induced malformation of cardiovascular system. Cell Death Dis. 2018;9:234. doi:10.1038/s41419-018-0318-229445081
   PubMed Web of Science ®Google Scholar
• ShuYJ, BaoR-F, WuX-S, et al. Baicalin induces apoptosis of gallbladder carcinoma cells in vitro via a mitochondrial-mediated pathway and suppresses tumor growth in vivo. Anticancer Agents Med Chem. 2014;14:1136–1145. doi:10.2174/187152061466614022319162624568162
   PubMed Web of Science ®Google Scholar
• SunJY, LiD-L, DongY, et al. Baicalin inhibits toll-like receptor 2/4 expression and downstream signaling in rat experimental periodontitis. Int Immunopharmacol. 2016;36:86–93. doi:10.1016/j.intimp.2016.04.01227107801
   PubMed Web of Science ®Google Scholar
• LiN, FelberK, ElksP, CroucherP, RoehlHH. Tracking gene expression during zebrafish osteoblast differentiation. Dev Dyn. 2009;238:459–466. doi:10.1002/dvdy.2183819161246
   PubMed Web of Science ®Google Scholar
• WuH, ZhongQ, WangJ, et al. Beneficial effects and toxicity studies of xian-ling-gu-bao on bone metabolism in ovariectomized rats. Front Pharmacol. 2017;8:273. doi:10.3389/fphar.2017.0027328588485
   PubMed Web of Science ®Google Scholar
• AoyamaE, KubotaS, KhattabHM, NishidaT, TakigawaM. CCN2 enhances RANKL-induced osteoclast differentiation via direct binding to RANK and OPG. Bone. 2015;73:242–248. doi:10.1016/j.bone.2014.12.05825554597
   PubMed Web of Science ®Google Scholar
• BoyceBF, XingL. Functions of RANKL/RANK/OPG in bone modeling and remodeling. Arch Biochem Biophys. 2008;473:139–146. doi:10.1016/j.abb.2008.03.01818395508
   PubMed Web of Science ®Google Scholar
• BreitkreutzI, RaabMS, ValletS, et al. Lenalidomide inhibits osteoclastogenesis, survival factors and bone-remodeling markers in multiple myeloma. Leukemia. 2008;22:1925–1932. doi:10.1038/leu.2008.17418596740
   PubMed Web of Science ®Google Scholar
• KRANESM. Drugs five years later: etidronate disodium in the treatment of Paget’s disease of bone. Ann Intern Med. 1982;96:619–625. doi:10.7326/0003-4819-96-5-6196280538
   PubMed Web of Science ®Google Scholar